Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	265.81	235.13	175.51	134.03	45.61	50.12
Revenue Growth (YoY)	20.62%	33.97%	30.95%	193.89%	-9.01%	15660.38%
Cost of Revenue	52.73	49.03	63.79	50.65	52.23	50.33
Gross Profit	213.08	186.1	111.72	83.38	-6.63	-0.21
Selling, General & Admin	109.57	172.03	195.04	196.37	173.54	97.27
Other Operating Expenses	16	1.55	2.48	-1.52	0.57	6.81
Operating Expenses	131.97	173.58	197.52	194.85	174.11	104.08
Operating Income	81.1	12.52	-85.79	-111.47	-180.74	-104.29
Interest Expense	-4.43	-4.84	-2.78	-	-	-
Interest & Investment Income	14.06	16.97	17	5.12	0.53	1.52
Currency Exchange Gain (Loss)	5.9	5.9	-5.9	-	-	-
EBT Excluding Unusual Items	96.64	30.55	-77.47	-106.35	-180.21	-102.77
Merger & Restructuring Charges	-17	-23.11	-	-	-	-
Pretax Income	79.64	7.45	-77.47	-106.35	-180.21	-102.77
Income Tax Expense	1.8	1.7	0.55	1.83	0.76	-0.09
Net Income	77.84	5.75	-78.02	-108.18	-180.97	-102.68
Net Income to Common	77.84	5.75	-78.02	-108.18	-180.97	-102.68
Shares Outstanding (Basic)	137	143	143	142	129	118
Shares Outstanding (Diluted)	142	146	143	142	129	118
Shares Change (YoY)	-1.24%	2.07%	0.93%	9.70%	9.20%	27.36%
EPS (Basic)	0.57	0.04	-0.54	-0.76	-1.40	-0.87
EPS (Diluted)	0.55	0.04	-0.54	-0.76	-1.40	-0.87
Free Cash Flow	119.64	44.11	-34.18	-79.82	-158	-75.53
Free Cash Flow Per Share	0.84	0.30	-0.24	-0.56	-1.22	-0.64
Gross Margin	80.16%	79.15%	63.66%	62.21%	-14.53%	-0.42%
Operating Margin	30.51%	5.32%	-48.88%	-83.17%	-396.31%	-208.09%
Profit Margin	29.28%	2.45%	-44.45%	-80.71%	-396.81%	-204.88%
Free Cash Flow Margin	45.01%	18.76%	-19.47%	-59.55%	-346.44%	-150.70%
EBITDA	100.55	31.96	-74.14	-108.76	-177.97	-102.92
EBITDA Margin	37.83%	13.59%	-42.24%	-81.15%	-	-205.35%
D&A For EBITDA	19.45	19.45	11.65	2.71	2.76	1.37
EBIT	81.1	12.52	-85.79	-111.47	-180.74	-104.29
EBIT Margin	30.51%	5.32%	-48.88%	-83.17%	-	-208.09%
Effective Tax Rate	2.26%	22.77%	-	-	-	-
Revenue as Reported	265.81	235.13	175.51	134.03	45.61	50.12

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q